1-94047046-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 5P and 1B. PM1PM5PP5BP4
The NM_000350.3(ABCA4):c.2791G>A(p.Val931Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 1,614,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V931L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000350.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ABCA4 | NM_000350.3 | c.2791G>A | p.Val931Met | missense_variant | 19/50 | ENST00000370225.4 | |
ABCA4 | XM_047416704.1 | c.2569G>A | p.Val857Met | missense_variant | 18/49 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ABCA4 | ENST00000370225.4 | c.2791G>A | p.Val931Met | missense_variant | 19/50 | 1 | NM_000350.3 | P1 | |
ABCA4 | ENST00000649773.1 | c.2569G>A | p.Val857Met | missense_variant | 18/19 |
Frequencies
GnomAD3 genomes AF: 0.00126 AC: 192AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000386 AC: 97AN: 251362Hom.: 0 AF XY: 0.000294 AC XY: 40AN XY: 135856
GnomAD4 exome AF: 0.000166 AC: 242AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.000140 AC XY: 102AN XY: 727248
GnomAD4 genome AF: 0.00127 AC: 194AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.00121 AC XY: 90AN XY: 74424
ClinVar
Submissions by phenotype
not provided Pathogenic:3Uncertain:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 931 of the ABCA4 protein (p.Val931Met). This variant is present in population databases (rs58331765, gnomAD 0.4%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with Stargardt disease (PMID: 9054934, 9973280, 19365591, 23755871, 28430335, 29114839, 30093795). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 7880). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 16, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 22264887, 27884173, 19365591, 9973280, 31456290, 9054934, 23755871, 30093795, 32619608, 24123366, 18977788, 35119454, 31816670, 27535533, 37498587, 35120629, 31964843, 32307445, 36011402) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 19, 2016 | - - |
not provided, no classification provided | literature only | Retina International | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 18, 2023 | The p.Val931Met variant in ABCA4 has been reported in the homozygous and compound heterozygous state in >10 individuals with Stargardt disease, however it was also found with other variants in ABCA4 in some affected individuals that could potentially explain their disease. This variant segregated with disease in 1 affected homozygous relative from a consanguineous family (Allikmets 1997 PMID: 9054934, Lewis 1999 PMID: 9973280, Maia-Lopes 2009 PMID: 19365591, Fujinami 2013 PMID: 23769331, Riveiro-Alvarez 2013 PMID: 23755871, Vallim-Salles 2017 PMID: 29114839, Pozo-Valero 2020 PMID: 32619608). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 7880). It has also been identified in 0.4% (177/41416) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.3.1.2), consistent with a recessive carrier frequency. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM3_Strong. - |
Severe early-childhood-onset retinal dystrophy Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 1997 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Feb 02, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with cone-rod dystrophy 3 (MIM#604116), fundus flavimaculatus (MIM#248200), early-onset severe retinal dystrophy (MIM#248200), retinitis pigmentosa 19 (MIM#601718) and Stargardt disease 1 (MIM#248200). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from valine to methionine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v3: 190 heterozygotes, 0 homozygote). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (p.(Val931Ala)) (7 heterozygotes, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0600 - Variant is located in the annotated ABC transporter domain 1 (UniProt). (I) 0708 - Another missense variant comparable to the one identified in this case has conflicting previous evidence for pathogenicity. The p.(Val931Leu) variant has been classified as both Pathogenic and Variant of Uncertain Significance, with limited or no evidence for their respective classification (ClinVar; PMID: 31213501). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been identified in multiple individuals with Stargardt disease; however it should be noted that some studies have also classified this variant as benign or likely benign (ClinVar; PMIDs: 9054934, 23755871, 23755871, 30093795, 23769331, 25082829, 31456290, 32619608). (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1102 - Strong phenotype match for this individual. (SP) 1201 - Heterozygous variant detected in trans with a second pathogenic heterozygous variant (NM_000350.2(ABCA4):c.4981del; p.(Leu1661*)) in a recessive disease. Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
not specified Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | Aug 08, 2022 | - - |
ABCA4-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 09, 2024 | The ABCA4 c.2791G>A variant is predicted to result in the amino acid substitution p.Val931Met. This variant has been reported in the compound heterozygous state many times in individuals with retinal dystrophy (see for examples Allikmets et al. 1997. PubMed ID: 9054934; Salles et al. 2018. PubMed ID: 30093795; Del Pozo-Valero et al. 2020. PubMed ID: 32619608; Table S2 in Sharon et al. 2020. PubMed ID: 31456290). This variant is reported in 0.44% of alleles in individuals of African descent in gnomAD, indicating it is relatively common. This variant has been listed as pathogenic or likely pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/7880/). Given the evidence, we interpret this variant as likely pathogenic. - |
Retinitis pigmentosa 19 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Jan 03, 2022 | Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000007880, PS1_S). A different missense change at the same codon has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000865894, PM5_M). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.664, PP3_P). A missense variant is a common mechanism associated with Retinitis pigmentosa 19 (PP2_P). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000474, PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jul 12, 2019 | - - |
Stargardt disease Pathogenic:1
Pathogenic, no assertion criteria provided | research | Sharon lab, Hadassah-Hebrew University Medical Center | Jun 23, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at